Researchers are working to accelerate the clinical adoption of novel allogeneic cell therapies to improve cancer care and treatment, according to a new report from the College of American Pathologists (CAP).
For the full article click here: Role of Pathologists in Improving Access to Safer, More Effective Allogeneic Cell Therapies